Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Abeona Therapeutics (ABEO) over the last 13 years, with Sep 2025 value amounting to -0.38%.

  • Abeona Therapeutics' Return on Capital Employed rose 17.00% to -0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.38%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.92% for FY2024, which is 1.00% up from last year.
  • Per Abeona Therapeutics' latest filing, its Return on Capital Employed stood at -0.38% for Q3 2025, which was up 28.69% from -0.54% recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Return on Capital Employed high stood at -0.38% for Q3 2025, and its period low was -2.90% during Q3 2022.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.81% (2025), whereas its average is -0.74%.
  • As far as peak fluctuations go, Abeona Therapeutics' Return on Capital Employed tumbled by 232bps in 2022, and later skyrocketed by 199bps in 2023.
  • Abeona Therapeutics' Return on Capital Employed (Quarterly) stood at -1.09% in 2021, then decreased by 8bps to -1.16% in 2022, then climbed by 25bps to -0.91% in 2023, then grew by 26bps to -0.65% in 2024, then grew by 17bps to -0.38% in 2025.
  • Its last three reported values are -0.38% in Q3 2025, -0.54% for Q2 2025, and -0.81% during Q1 2025.